Literature DB >> 35412612

Comparative Effectiveness of mRNA and Inactivated Whole-Virus Vaccines Against Coronavirus Disease 2019 Infection and Severe Disease in Singapore.

M Premikha1, Calvin J Chiew1, Wycliffe E Wei1, Yee Sin Leo2,3,4,5,6, Benjamin Ong1,4, David Chien Lye2,3,4,5, Vernon J Lee1,6, Kelvin Bryan Tan1,6.   

Abstract

Compared with individuals vaccinated with Pfizer-BioNTech/Comirnaty, recipients of Sinovac-CoronaVac and Sinopharm were 2.37 (95% CI, 2.29-2.46) and 1.62 (95% CI, 1.43-1.85) times more likely to be infected with coronavirus disease 19, respectively, while individuals vaccinated with Moderna were 0.42 (95% CI, 0.25-0.70) times less likely to develop severe disease.
© The Author(s) 2022. Published by Oxford University Press on behalf of the Infectious Diseases Society of America. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  COVID-19; SARS-CoV-2; inactivated vaccine; mRNA vaccine; vaccines

Mesh：

Substances：

Year:  2022        PMID： 35412612      PMCID： PMC9047219          DOI： 10.1093/cid/ciac288

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   20.999


  7 in total

1.  Kinetics of the Neutralizing and Spike SARS-CoV-2 Antibodies following the Sinovac Inactivated Virus Vaccine Compared to the Pfizer mRNA Vaccine in Singapore.

Authors:  Chin Shern Lau; May Lin Helen Oh; Soon Kieng Phua; Ya Li Liang; Yanfeng Li; Jianxin Huo; Yuhan Huang; Biyan Zhang; Shengli Xu; Tar Choon Aw
Journal:  Antibodies (Basel)       Date:  2022-05-27

Review 2.  Lessons from SARS‑CoV‑2 and its variants (Review).

Authors:  Ziwen Qin; Yan Sun; Jian Zhang; Ling Zhou; Yujuan Chen; Chuanjun Huang
Journal:  Mol Med Rep       Date:  2022-06-22       Impact factor: 3.423

3.  Effectiveness of inactivated and Ad5-nCoV COVID-19 vaccines against SARS-CoV-2 Omicron BA. 2 variant infection, severe illness, and death.

Authors:  Zhuoying Huang; Shuangfei Xu; Jiechen Liu; Linlin Wu; Jing Qiu; Nan Wang; Jia Ren; Zhi Li; Xiang Guo; Fangfang Tao; Jian Chen; Donglei Lu; Xiaodong Sun; Weibing Wang
Journal:  BMC Med       Date:  2022-10-20       Impact factor: 11.150

Review 4.  The life and death of RNA across temperatures.

Authors:  Attila Becskei; Sayanur Rahaman
Journal:  Comput Struct Biotechnol J       Date:  2022-08-08       Impact factor: 6.155

5.  Effectiveness of BNT162b2 and CoronaVac vaccinations against mortality and severe complications after SARS-CoV-2 Omicron BA.2 infection: a case-control study.

Authors:  Vincent Ka Chun Yan; Eric Yuk Fai Wan; Xuxiao Ye; Anna Hoi Ying Mok; Francisco Tsz Tsun Lai; Celine Sze Ling Chui; Xue Li; Carlos King Ho Wong; Philip Hei Li; Tiantian Ma; Simon Qin; Vincent Kai Chung Wong; Tat Chi Tsang; Sik Hon Tsui; William Chun Ming Chui; Benjamin John Cowling; Gabriel Matthew Leung; Chak Sing Lau; Ian Chi Kei Wong; Esther Wai Yin Chan
Journal:  Emerg Microbes Infect       Date:  2022-12       Impact factor: 19.568

6.  A comparative characterization of SARS-CoV-2-specific T cells induced by mRNA or inactive virus COVID-19 vaccines.

Authors:  Joey Ming Er Lim; Shou Kit Hang; Smrithi Hariharaputran; Adeline Chia; Nicole Tan; Eng Sing Lee; Edwin Chng; Poh Lian Lim; Barnaby E Young; David Chien Lye; Nina Le Bert; Antonio Bertoletti; Anthony T Tan
Journal:  Cell Rep Med       Date:  2022-10-06

7.  Comparative analysis of mRNA and inactivated COVID-19 vaccines: A study from Faisalabad district of Pakistan.

Authors:  Syed Ata Ul Munamm; Iftikhar Nadeem; Noor Mahdi; Muhammad Saqlain; Zaid Khalid Rana; Usman Feroze Khatana; Umer Mustansir Bhatty; Visakan Navayogaarajah; Fatimah Mahsal Khan; Masood Ur Rasool
Journal:  J R Coll Physicians Edinb       Date:  2022-10-12
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.